A magnesium-platinum galvanic cell composite microsphere with electrostimulation function, its preparation method and application
By coating magnesium microspheres with a porous inorganic shell and a platinum nanoparticle cathode, and introducing a pH-responsive polymer layer on the outer layer, the problems of electrode integration instability and uncontrollable reaction kinetics of galvanic cell composite microspheres in liquid environment are solved, enabling long-term sustained release and large-scale preparation, and possessing multifunctional synergistic output.
Patent Information
- Application Number
- CN202611164456.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-03
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2046-08-03
AI Technical Summary
Existing composite microspheres for galvanic cells have unstable electrode integration in liquid environments, uncontrollable reaction kinetics, lack of environmentally responsive initiation and control functions, insufficient synergy between catalytic function and mass transfer regulation, and difficulty in achieving long-term sustained release and large-scale preparation through microstructure design.
Magnesium microspheres were used as the anode, with a porous inorganic shell covering the anode surface. Platinum nanoparticles were loaded as the cathode, and a pH-responsive polymer layer was coated on the outer layer. A multilayer structure was formed by sol-gel method and layer-by-layer self-assembly technology, and the structure was prepared by physical vapor deposition and spray drying.
It achieves stable potential difference output, catalytic active hydrogen generation, and intelligent pH response controlled release, overcoming the problems of unstable electrochemical output and unsustainable reaction in existing technologies, and has the capability for long-term sustained release and large-scale preparation.
Smart Images

Figure CN122696705B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of microsphere preparation technology, specifically to a magnesium-platinum galvanic cell composite microsphere with electrostimulation function, its preparation method, and its application. Background Technology
[0002] Micron-scale galvanic cell composite particles are a class of functional materials that integrate two or more materials with different electrochemical activities into a single microsphere unit, enabling them to spontaneously form micro-galvanic cells in a liquid environment. These materials typically use an active metal (such as magnesium, zinc, aluminum, etc.) or its alloy as the anode and an inert conductive material (such as platinum, gold, silver, carbon, etc.) as the cathode. A potential difference is formed in an aqueous body liquid, driving the simultaneous occurrence of anodic oxidation and cathodic reduction reactions, thereby achieving functions such as in-situ hydrogen production, electron output, or the generation of active species. Compared with traditional macroscopic electrochemical systems or nanoparticle dispersion systems, micron-scale galvanic cell composite particles exhibit unique advantages and broad prospects in areas such as microreactor construction, self-powered systems, and locally controllable chemical transformation.
[0003] However, research on composite microspheres for galvanic cells is still in its early stages, and their material design and functional realization face the following common technical challenges: (1) Insufficient electrode integration method and structural stability. Existing composite particles for galvanic cells are mostly constructed using simple physical mixing, surface adsorption, or discontinuous loading methods, lacking a stable bridging structure and precise spatial configuration between the anode and cathode. This loose electrode connection is easily separated during liquid-phase reactions due to anode dissolution or bubble erosion, leading to galvanic cell circuit breakage, premature loss of function, and difficulty in maintaining stable electrochemical output for a long time.
[0004] (2) The reaction kinetics are uncontrollable and lack long-term sustained-release capability. When the active anode metal comes into contact with the aqueous solution, due to the lack of an effective mass transfer barrier layer, the anodic oxidation reaction occurs rapidly in the initial stage, and the release of hydrogen or active products exhibits an "explosive" characteristic, with the effective action time usually measured in minutes or hours. This uncontrollable rapid consumption mode not only causes waste of the material itself, but also limits its application in scenarios that require continuous and stable functional output.
[0005] (3) Lack of environmentally responsive start-up control function. Existing galvanic cell composite particles are usually in a "naked" state. Once they come into contact with the liquid environment, the reaction is irreversibly initiated. They cannot be selectively triggered or paused based on external environmental conditions (such as pH value, ionic strength, etc.). Especially for application paths that need to traverse multiple pH environments (such as from acidic to neutral / alkaline), the particles are prematurely exhausted before reaching the target site, making it impossible to achieve on-demand start-up control and precise functional release.
[0006] (4) Insufficient synergy between catalytic function and mass transfer regulation. Most current studies focus on the selection of anode materials or simple cathode loading, failing to systematically design the synergistic integration of catalytic active sites and mass transfer pathways within the microsphere unit. The catalytic efficiency on the cathode side is limited, and the anode hydrolysis products (such as hydrogen) cannot be further converted into species with higher reactivity. At the same time, the porous shell structure lacks a matching design between the mass transfer regulation of reactants and products and the catalytic function, making it difficult to optimize the overall chemical conversion efficiency and product selectivity.
[0007] (5) The contradiction between the customizability of microstructures and large-scale preparation. Constructing composite microspheres for galvanic cells with precise core-shell-shell multilayer structures places strict and independently controllable requirements on shell thickness, porosity, cathode loading and distribution uniformity, and the integrity of the outer protective coating. However, existing preparation methods either rely on high-temperature sintering or are difficult to achieve modular assembly and parameterized control of each layer, which restricts the rational design and large-scale preparation of such materials.
[0008] Taking magnesium-based galvanic cell composite microspheres as an example, although common magnesium microparticles (Mg MPs) or simple magnesium / silica core-shell composite materials (Mg@SiO2) in existing technologies can react with water to produce hydrogen gas, they still have significant drawbacks: Ordinary magnesium particles (Mg MPs): The exposed surface of metallic magnesium undergoes a violent reaction in acidic environments (such as pH 1.0-3.0), with explosive hydrogen release, releasing most of the hydrogen production within 2 hours, making it impossible to maintain long-term stable reaction kinetics. Furthermore, the lack of a cathode coupling design prevents the formation of an effective electrode pair, resulting in low electron transfer efficiency and limited chemical reactivity of the hydrogen products.
[0009] Magnesium / silica core-shell particles (Mg@SiO2): Although a certain degree of physical isolation is achieved through SiO2 coating, the SiO2 shell is prone to dissolution or structural damage under strongly acidic conditions, leading to premature leakage and premature reaction. In addition, this system lacks a systematic design of cathode catalytic components, making it impossible to further convert the H2 produced by hydrolysis into more reactive hydrogen species (such as H·), and also impossible to regulate the reaction pathway and product selectivity through the galvanic effect.
[0010] In summary, in the field of micron-scale composite functional materials for galvanic cells, there is an urgent need to develop a novel composite microsphere system with stable electrode integration, long-term controllable kinetics, environmentally responsive start-up, and synergistic optimization of catalysis and mass transfer, so as to realize the on-demand release of material functions and customized design of performance. However, there are currently no reports on core-shell-shell multilayer structure composite microspheres for galvanic cells with the above comprehensive properties and their scalable preparation methods. Summary of the Invention
[0011] The purpose of this invention is to provide a magnesium-platinum galvanic cell composite microsphere with electrostimulation function, its preparation method, and its application, so as to solve the problems of lack of long-term sustained-release capability and insufficient support for multifunctional synergy in existing magnesium microsphere functional materials.
[0012] To achieve the above objectives, the present invention provides the following technical solution: In a first aspect, the present invention provides a galvanic cell composite microsphere with electrical stimulation function, comprising: Metal microspheres serve as the anode; A porous inorganic shell is coated on the surface of the metal microspheres to control the water permeation rate; A cathode material, loaded on the surface of the porous inorganic shell, serves as the cathode; and A pH-responsive polymer layer is coated on the outermost layer. It remains solid and insoluble in an environment with pH ≤ 5.5, and dissolves in an environment with pH ≥ 7.0. The metal microspheres and the cathode form a galvanic cell system after water molecules penetrate into them, generating microcurrents and hydrogen gas in an environment with pH ≥ 7.0.
[0013] In some embodiments, the metal microspheres are selected from at least one of magnesium microspheres, magnesium-based alloy microspheres, zinc microspheres, or iron microspheres; the magnesium-based alloy is selected from one or more of Mg-Zn alloys, Mg-Ca alloys, Mg-Mn alloys, or Mg-Sr alloys.
[0014] Magnesium alloys also possess biodegradability and high chemical activity. By doping with other metals, the corrosion potential and degradation rate can be adjusted (e.g., Mg-Zn degradation is typically slower than pure Mg), thus achieving slow release without relying on an excessively thick SiO2 layer. Zinc is also an essential trace element for the human body and has good biocompatibility. Although zinc's standard electrode potential (-0.76 V) is higher than magnesium's (-2.37 V), it can still form a galvanic cell with platinum or gold to generate a microcurrent. Its hydrolysis to produce hydrogen is relatively slow, making it suitable for scenarios requiring longer-lasting (>24 hours) release. Iron is a biodegradable metal, and although its hydrogen production capacity is weak, it can still constitute the anode of a galvanic cell under specific acidic microenvironments or in the presence of a catalyst.
[0015] In some embodiments, the porous inorganic shell is selected from at least one of a silica shell, a titanium dioxide shell, a zinc oxide shell, a polymer layer, or a natural polysaccharide gel layer; the polymer is selected from at least one of polylactic acid-glycolic acid copolymer, polylactic acid, or polycaprolactone; and the natural polysaccharide gel is selected from at least one of alginate or chitosan.
[0016] TiO2 or ZnO, when coated using the sol-gel method, can also form a porous inorganic shell, controlling the rate of water permeation and inhibiting the explosive reaction of magnesium. Polymers degrade slowly in vivo; by controlling the thickness or porosity of the polymer film, the rate at which water contacts the magnesium core can be more precisely regulated, achieving ultra-long-term sustained release lasting for days or even weeks. Natural polysaccharide gels can be coated using layer-by-layer self-assembly (LBL) technology to form a hydrophilic gel network, delaying water molecule diffusion.
[0017] In some embodiments, the cathode material is selected from at least one of platinum nanoparticles, gold nanoparticles, palladium nanoparticles, silver nanoparticles, ruthenium nanoparticles, carbon-based nanomaterials, or conductive polymers; the carbon-based nanomaterials are selected from at least one of graphene, reduced graphene oxide, carbon nanotubes, or mesoporous carbon; and the conductive polymer is selected from at least one of polypyrrole or polyaniline.
[0018] Palladium (Pd) possesses extremely strong hydrogen storage and catalytic hydrogen activation capabilities, very similar to Pt. Gold (Au) exhibits excellent conductivity and bioinertness, forming a significant potential difference (electromotive force) with magnesium, driving electron flow to generate electrical stimulation. Carbon materials have good conductivity and a higher potential than magnesium, making them suitable as cathodes for constructing magnesium-carbon (Mg-C) batteries. Although their ability to catalyze the conversion of hydrogen into active hydrogen (H·) is weaker than platinum, they are less expensive and still generate electrical stimulation and hydrogen. Conductive polymers possess good biocompatibility and conductivity, making them suitable as non-metallic cathodes.
[0019] In some embodiments, the pH-responsive polymer layer is selected from at least one of Eudragit S100, hydroxypropyl methylcellulose phthalate, and cellulose acetate phthalate.
[0020] The pH-responsive polymer layer is used to maintain the structural stability of the composite microspheres in an acidic gastric environment and to dissolve and release the Mg@SiO2-Pt composite microspheres in the intestinal pH environment.
[0021] As an alternative technical solution, Eudragit S100 can be replaced with a colon-specific degradable material selected from one of azo polymers, pectin, and guar gum.
[0022] Colon-specific degradable materials are not pH-dependent, but are degraded by specific microbial enzymes in the colon, enabling more precise colon targeting.
[0023] As alternative technologies, physical vapor deposition (PVD) / sputtering is used: a platinum or silica film is directly sputtered onto the surface of magnesium microspheres. This method allows for precise control of film thickness and leaves no solvent residue. Spray drying is used for coating the outermost enteric polymer layer. This method has high industrial production efficiency and is more suitable for large-scale preparation than oil / oil emulsion methods. Fluidized bed coating is a commonly used microparticle coating technology in pharmaceuticals. This method is suitable for the uniform coating of micron-sized particles.
[0024] Secondly, the present invention provides a method for preparing magnesium-platinum galvanic cell composite microspheres with electrical stimulation function, comprising the following steps: S1, the porous inorganic shell is coated on the surface of the metal microspheres to prepare an anode substrate with slow-release function; S2, perform surface functionalization modification on the anode substrate; S3, the cathode material is loaded onto the surface of the porous inorganic shell to form a cathode; S4, the pH-responsive polymer layer is coated onto the outermost layer of the material formed in step S3, and microencapsulation is performed to prepare the magnesium-platinum galvanic cell composite microsphere with the electrostimulation function.
[0025] In some implementations, the specific steps include: A1. Magnesium microspheres are dispersed in a mixture of acetone and ammonia. Tetraethyl orthosilicate is added dropwise under stirring. After reacting for 6-15 hours, the solid and liquid are separated to obtain magnesium microspheres Mg@SiO2 coated with a silica shell. The volume / mass ratio of tetraethyl orthosilicate to magnesium microspheres is 1 ml: (125-500 mg). A2. Disperse the Mg@SiO2 microspheres obtained in step S1 in a mixture of acetone and ammonia water containing 10-30% ammonia by mass, add a mixed solution of 3-aminopropyltriethoxysilane and tetraethyl orthosilicate, and react for 4-8 hours to obtain microspheres with amino functional groups on the surface; wherein, the volume / mass ratio of 3-aminopropyltriethoxysilane, tetraethyl orthosilicate and Mg@SiO2 is (10-30 ml): (30-90 ml): 1 mg; A3. Disperse the microspheres with amino functional groups obtained in step S2 in an aqueous solution of potassium chloroplatinate, add ascorbic acid and carry out an in-situ reduction reaction for 1-3 hours to obtain Mg@SiO2-Pt composite microspheres; wherein, the mass ratio of the microspheres with amino functional groups, potassium chloroplatinate and ascorbic acid is 40-80:2-4:1-2. A4. The Mg@SiO2-Pt composite microspheres obtained in step S3 are dispersed in an isopropanol solution containing Eudragit S100. Using liquid paraffin as the continuous phase, microcapsules are prepared by oil / oil emulsion solvent evaporation method to obtain the magnesium-platinum galvanic cell composite microspheres Mg@SiO2-Pt@ES.
[0026] In some embodiments, the average particle size of the magnesium microspheres is 20-50 μm, and the thickness of the silica shell is 50-200 nm.
[0027] Through the above technical solution, this invention successfully constructed a micron-scale Mg-Pt galvanic cell system. This design achieves the following three major technological breakthroughs from the perspective of material functional synergy: (1) Self-powered electrochemical characteristics and electrostimulation output function: Using magnesium microspheres as the anode and in-situ loaded platinum nanoparticles as the cathode, a micron-scale galvanic cell unit is spontaneously formed in an aqueous body fluid environment, generating a stable potential difference (approximately -0.65V), driving the directional migration of electrons to form a continuous microcurrent. This self-powered electrochemical characteristic is not possessed by existing Mg@SiO2 materials, upgrading the material from a single chemical hydrogen production system to a multifunctional microreactor with synergistic output of both chemical and electrical energy. The output microcurrent signal and the synchronously generated hydrogen molecules together constitute a dual physical-chemical stimulation source, which can exert an active electroregulatory effect on the external environment or interface.
[0028] (2) Enhanced active hydrogen generation and high-efficiency antioxidant capacity through surface catalysis: Platinum nanoparticles, acting as the cathode functional layer, not only accelerate the electron transfer process in the magnesium oxidation reaction, but also, thanks to their excellent catalytic activity, partially convert the hydrogen molecules generated from magnesium hydrolysis into atomic hydrogen (H·), which has higher reactivity. This synergistic system of H2 and H· significantly improves the material's resistance to stubborn oxidants (such as hydroxyl radicals ·OH, peroxynitrite ONOO). - The removal rate and efficiency of (etc.) show that it has a broader spectrum and more efficient in-situ antioxidant performance than single hydrogen-producing materials.
[0029] (3) Intelligent pH-responsive controlled release and long-term sustained release mechanism: The outermost layer is introduced with a pH-responsive polymer coating (Eudragit S100), which endows the material with the dual characteristics of maintaining structural integrity in acidic environments and dissolving the coating and initiating a galvanic cell reaction in environments with a pH value greater than 7, thus realizing intelligent release control based on pH triggering of material function. At the same time, by adjusting the feeding ratio of tetraethyl orthosilicate to magnesium, the thickness of the intermediate porous silica shell can be controlled, thereby adjusting the mass transfer rate of water molecules to the magnesium core, realizing customized control of the continuous release time of hydrogen and microcurrent (which can cover a continuous action window of several hours to more than ten hours), breaking through the limitation of short-term explosive release of conventional magnesium-based materials.
[0030] By adjusting the volume / mass ratio of tetraethyl orthosilicate to magnesium to 1 ml: 250 mg and controlling the SiO2 layer thickness to 100 nm, continuous hydrogen release can be achieved for more than 8 hours, while ordinary magnesium particles can only maintain it for less than 2 hours.
[0031] In some embodiments, in step S3, the mass ratio of the microspheres with amino functional groups, potassium chloroplatinate, and ascorbic acid is preferably 40:2:1.
[0032] In some embodiments, in step S3, platinum nanoparticles are loaded onto the pores and surface of the silica shell by in-situ reduction, and the platinum nanoparticles serve as a cathode material to form a magnesium-platinum galvanic cell structure with magnesium microspheres.
[0033] Thirdly, the present invention also provides the application of electrically stimulating galvanic cell composite microspheres in the preparation of a drug, wherein the drug is used to achieve any of the following functions: a. activating intestinal nociceptors; b. promoting the release of endogenous calcitonin gene-related peptide CGRP; c. scavenging hydroxyl radicals.
[0034] More specifically, it is used to prepare drugs for the prevention and treatment of radiation enteritis or ulcerative colitis.
[0035] Based on the above technical solution, the embodiments of the present invention can produce at least the following technical effects: (1) Significant improvement in material functional integration: This invention is the first to realize a three-in-one structural design of "self-powered galvanic cell + catalytic active site + intelligent response coating" at the micron scale. By organically integrating the anode (magnesium core), cathode (platinum nanoparticles), mass transfer regulation layer (porous silica), and environmentally responsive encapsulation layer (pH-responsive polymer) into a single microsphere unit, the material simultaneously possesses multiple functions such as in-situ energy supply, catalytic conversion, electrical signal output, and intelligent start-up control, breaking through the technical bottleneck of existing magnesium-based materials having single functions and lacking electrochemical regulation capabilities.
[0036] (2) Synergistic optimization of electrochemical performance and stability: The material can spontaneously generate a stable potential difference of about -0.65V and output a continuous microcurrent in an aqueous liquid environment. This self-powered electrochemical characteristic, after being regulated by the mass transfer of the porous silica shell, avoids the common problems of initial current jump and rapid decay in magnesium-based materials. By adjusting the feed ratio of tetraethyl orthosilicate to magnesium, silica shells of different thicknesses (such as about 100 nm to hundreds of nanometers) can be prepared in a controllable manner, realizing programmable control of magnesium hydrolysis rate, hydrogen release curve and current output duration, so that the functional validity period of the material can be customized as needed within the range of several hours to more than ten hours.
[0037] (3) Customizable structure and controllable preparation process: This invention achieves fully controllable preparation from the core to the outer layer by combining the improved Stöber method with in-situ removal reduction and emulsion coating technology. Key structural parameters such as silica shell thickness, platinum nanoparticle loading and distribution density, and outer polymer coating thickness can all be independently controlled by adjusting process conditions (precursor dosage, reaction time, polymer concentration, etc.), giving the material structure-performance relationship a customizable design capability. Moreover, the preparation process does not require high-temperature sintering or high-vacuum equipment, making it feasible for large-scale preparation.
[0038] (4) The Mg@SiO2-Pt@ES of this invention can be used to treat radiation enteritis. It can quickly remove more than 65% of the highly toxic hydroxyl radicals (·OH) and reduce the radiation-induced intracellular ROS level from 100% in the control group to 14%. The effect is 1.4 times that of the clinical drug amifostine. The Eudragit S100 coating provides perfect protection in the acidic environment of the stomach (pH 2.0) and responds quickly to release in the intestinal environment (pH 7.4), which solves the side effects of gastric reaction and bloating of magnesium-based materials. Attached Figure Description
[0039] To more clearly illustrate the technical solutions in this invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this invention. For those skilled in the art, other drawings can be obtained based on the structures shown in these drawings without creative effort.
[0040] Figure 1 This is a schematic diagram of the magnesium-platinum galvanic cell composite microspheres of the present invention used for the treatment of radiation enteritis.
[0041] Figure 2 This is a schematic diagram illustrating the working principle of the magnesium-platinum galvanic cell composite microspheres of the present invention.
[0042] Figure 3 This is a morphological structure analysis diagram of the Mg@SiO2-Pt@ES prepared in Example 1 of this invention. Figure 3 The first image from the left is a scanning electron microscope image of Mg@SiO2-Pt@ES; the second image from the left is a magnified view of a single particle; the third image from the left is a magnified view of a part of the particle; and the first image from the right is a particle size distribution map of Mg@SiO2-Pt@ES. Figure 3 b is the EDS energy spectrum of Mg@SiO2-Pt@ES; Figure 3 c is a high-magnification scanning electron microscope image of Mg@SiO2-Pt@ES.
[0043] Figure 4These are the TGA curves and XRD patterns of the Mg@SiO2-Pt and Mg@SiO2-Pt@ES galvanic cells prepared in Example 1 of this invention. Figure 4 a represents the TGA curve of Mg@SiO2-Pt@ES; Figure 4 b is the XRD pattern of Mg@SiO2-Pt@ES.
[0044] Figure 5 This is an optical imaging image of the release behavior of Mg and Mg@SiO2 in simulated intestinal fluid according to the present invention. Figure 5 A represents the release of uncoated Mg particles in simulated intestinal fluid; Figure 5 B represents the release behavior of Mg@SiO2 particles under the condition of tetraethyl orthosilicate to magnesium volume / mass ratio of 1 ml: 125 mg; Figure 5 C represents the release behavior of Mg@SiO2 particles under the condition of tetraethyl orthosilicate to magnesium volume / mass ratio of 1 ml: 250 mg; Figure 5 D represents the release behavior of Mg@SiO2 particles under the condition of tetraethyl orthosilicate to magnesium volume / mass ratio of 1 ml: 500 mg.
[0045] Figure 6 This is a graph showing the hydrogen release curves of Mg@SiO2 particles with different SiO2 shell thicknesses under different TEOS / Mg volume / mass ratios according to the present invention.
[0046] Figure 7 The graph shows the hydrogen-targeted release test results of the Mg@SiO2-Pt@ES prepared in Example 1 of this invention under different pH conditions.
[0047] Figure 8 These are abdominal ultrasound imaging results at different time points after oral administration of the present invention.
[0048] Figure 9 This includes the Tafel curves of the Mg@SiO2 particles and the Mg@SiO2-Pt galvanic cell of this invention in simulated intestinal fluid, as well as the reduction peak potential diagram of Mg@SiO2 obtained based on cyclic voltammetry (CV) analysis. Figure 9 a represents the Tafel curves of Mg@SiO2 particles and Mg@SiO2-Pt galvanic cells in simulated intestinal fluid; Figure 9 b is the cyclic voltammetry curve of Mg@SiO2.
[0049] Figure 10 This is a graph showing the assessment results of intracellular reactive oxygen species levels and mitochondrial membrane potential (ΔΨm) in MODE-K cells according to the present invention. Figure 10 The left image in figure a is a fluorescence micrograph, which qualitatively and intuitively shows the distribution of reactive oxygen species fluorescence in MODE-K cells. The right image is a bar chart, which is the quantitative statistical result of mean fluorescence intensity (MFI). Figure 10The left image in b is a fluorescence micrograph, which qualitatively and intuitively shows the mitochondrial damage status of each group. The right image is the quantitative statistical result of the ratio of JC aggregated state to monomer fluorescence intensity.
[0050] Figure 11 This is an in vivo therapeutic efficacy verification diagram for radiation enteritis according to the present invention. Figure 11 a is an H&E staining image of an ileal tissue section; Figure 11 b is an organizational structure analysis diagram; Figure 11 c is a diagram showing the release of calcitonin gene-related peptide (CGRP) triggered by the Mg@SiO2-Pt@ES galvanic cell; Figure 11 d is a graph showing the quantitative analysis of CGRP levels in the small intestine using ELISA; Figure 11 e is a graph showing the quantitative analysis of colonic CGRP levels by ELISA; Figure 11 f is an immunofluorescence staining image of a colon tissue section with MUC2; Figure 11 g is the result of the mucus layer thickness in a colon tissue section.
[0051] Figure 12 This is a diagram showing the protective effect of Mg@SiO2-Pt@ES against lethal radiation damage in mice. Figure 12 Figure a shows the survival rate analysis of the whole-body irradiation mouse model. Figure 12 b is a graph showing the survival rate analysis of the whole-abdomen irradiation mouse model; Figure 12 c is a graph showing the weight analysis of the whole-body irradiation mouse model; Figure 12 d is a graph showing the analysis of the body weight of a mouse model subjected to full abdominal irradiation; Figure 12 e-treadmill experiment; Figure 12 f is a graph analyzing the number of electrical stimulations during the treadmill experiment; Figure 12 g represents the accelerated rotating rod experiment; Figure 12 h is a graph showing the residence time analysis under the accelerated rotor experiment. Detailed Implementation
[0052] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0053] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Every smaller range between any stated value or intermediate value within a stated range, and any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.
[0054] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.
[0055] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be apparent to those skilled in the art. This specification and embodiments are merely exemplary.
[0056] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.
[0057] The atomized spherical magnesium powder (Mg Microparticles, Mg MPs) used in the following embodiments of the present invention were purchased from Tangshan Weihou Magnesium Powder Co., Ltd. Tetraethyl orthosilicate (TEOS), (3-aminopropyl)triethoxysilane (APTES), and potassium chloroplatinate (K2PtCl6) were purchased from Sigma-Aldrich reagents. Eudragit S100, liquid paraffin, and ascorbic acid were purchased from Aladdin Reagents (Shanghai) Co., Ltd. Experimental animals: C57BL / 6J mice (8 weeks old) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd.
[0058] Example 1: Preparation of Mg@SiO2-Pt@ES galvanic cell composite microspheres In this embodiment, composite microspheres with a volume / mass ratio of tetraethyl orthosilicate to magnesium of 1 ml: 250 mg were prepared, yielding a silica shell with a thickness of approximately 100 nm. The preparation steps are as follows: (1) Preparation of Mg@SiO2: Atomized spherical magnesium powder was washed with acetone to remove surface impurities. 400 mg of the washed atomized spherical magnesium powder was dispersed in a mixture of 30 mL acetone and 2 mL ammonia water containing 28% ammonia by mass. Under mechanical stirring, a solution consisting of 1.6 mL tetraethyl orthosilicate dissolved in 20 mL acetone was slowly added dropwise over 1 hour. After reacting for 12 hours, the precipitate was collected by centrifugation and washed three times with acetone to obtain Mg@SiO2 microspheres.
[0059] (2) Surface amination modification: 400 mg of Mg@SiO2 microspheres obtained in step (1) were dispersed in a mixture of 30 mL acetone and 1 mL ammonia water containing 28% ammonia by mass. Under stirring, a mixed solution consisting of 80 µL (3-aminopropyl)triethoxysilane, 240 µL tetraethyl orthosilicate and 20 mL acetone was added dropwise over 1 hour. The reaction was continued for 5 hours, followed by centrifugation and washing to obtain surface amination microspheres.
[0060] (3) Construction of Mg@SiO2-Pt: The product of step (2) was dispersed in deionized water, and 100 µL of potassium chloroplatinate solution (200 mg / mL) was added. After mixing, 10 mg of ascorbic acid was added as a reducing agent. The reaction was carried out at room temperature for 2 hours, centrifuged and washed, and dried under vacuum at 40 °C to obtain Mg@SiO2-Pt galvanic cell microspheres.
[0061] (4) Microencapsulation of enteric coating (Mg@SiO2-Pt@ES): 40 mg of Mg@SiO2-Pt galvanic cell microspheres were uniformly dispersed in 2 mL of isopropanol containing 6.5% (w / v) Eudragit S100. This mixture was then injected into 20 mL of liquid paraffin under stirring to form a stable oil-in-oil emulsion. The mixture was stirred continuously at 55°C for 24 hours to allow the isopropanol to evaporate completely. The microspheres were collected by centrifugation, washed with n-hexane, and cured at 70°C. The surface was rapidly rinsed with 0.1 M dilute hydrochloric acid, and finally vacuum dried at 40°C to obtain the final product.
[0062] Those skilled in the art will understand that the technical objective of this invention can be achieved by appropriately adjusting the reaction time within the above-mentioned time range.
[0063] like Figure 1-2 The diagram shown is a schematic of the present invention. Mg@SiO2 consists of a magnesium microsphere (Mg MPs) core and a porous silica (SiO2) layer covering its surface. The magnesium core acts as the anode of the galvanic cell, providing an electron source (Mg-2e). - →Mg 2+ ); The silica layer acts as a physical barrier to regulate the hydrolysis rate of magnesium. A porous silica layer is grown in situ on the magnesium surface to obtain the Mg@SiO2 intermediate, which provides a stable anode substrate for the subsequent construction of the galvanic cell. After amination modification, the adsorption capacity of the cathode material (platinum precursor) on the surface of the anode substrate is enhanced. (3) Pt is deposited in situ on the surface of the Mg@SiO2 substrate. The introduction of Pt transforms the material from ordinary chemical reaction particles into a "micron galvanic cell". Pt, as the cathode, forms a significant potential difference with the Mg anode, driving the directional flow of electrons and generating a microcurrent (electric stimulation). Catalyze the hydrogen evolution reaction (2H2O+2e) - →2OH -The process involves adding H2 and catalyzing the conversion of some hydrogen molecules into highly reactive atomic hydrogen (H·), significantly improving the efficiency of reactive oxygen species scavenging. The enteric polymer coating (Eudragit S100) is a pH-responsive polymer membrane encapsulated on the outermost layer of galvanic cell microspheres. It is a key means to solve the problems of structural damage and premature release of existing magnesium-based materials in gastric acid. This coating remains intact in gastric acid (pH<7), isolating water molecules; it dissolves only in the intestinal environment (pH>7), thereby initiating the galvanic cell reaction and achieving precise intestinal-targeted therapy.
[0064] Example 2 Preparation of thin-shell Mg@SiO2-Pt@ES The only difference from Example 1 is that the amount of tetraethyl orthosilicate used in step (1) is adjusted to 0.8 mL (the volume / mass ratio of tetraethyl orthosilicate to magnesium is 1 mL: 125 mg), and the rest of the steps are the same. Compared with Example 1, the microspheres prepared in this example have a thinner SiO2 shell, resulting in a faster hydrogen release rate and a shorter duration (approximately 4 hours). This indicates that under the same conditions, the thinner the silica layer, the faster the hydrogen release rate.
[0065] Example 3 Preparation of thick-shell Mg@SiO2-Pt@ES The only difference from Example 1 is that the amount of tetraethyl orthosilicate used in step (1) is adjusted to 3.2 mL (the volume / mass ratio of tetraethyl orthosilicate to magnesium is 1 ml: 500 mg), and the other steps are the same. Compared with Example 1, the microspheres prepared in this example have a thicker SiO2 shell, resulting in slower hydrogen release, longer-lasting sustained-release performance, and a duration that can be extended to more than 12 hours.
[0066] Comparative Example 1: Uncoated Mg MPs Commercially available, untreated, spherical magnesium powder for atomization was used directly, without SiO2, Pt, or Eudragit S100 coating. This was used to compare sustained-release performance and gastric acid stability.
[0067] Comparative Example 2: Platinum-free composite microspheres (Mg@SiO2) The difference from Example 1 is that potassium chloroplatinate and ascorbic acid are not added in step (3), that is, no platinum catalyst is loaded, and the enteric coating in step (4) is carried out directly. This is used to verify the key role of platinum (Pt) in the construction of galvanic cells, electrical stimulation generation, and active hydrogen catalysis.
[0068] Comparative Example 3 Amifostine Amifostine, a clinically used radiation protection drug, was used. In animal experiments, it was administered via intraperitoneal injection (200 mg / kg) one hour before irradiation to compare the therapeutic effects of this invention.
[0069] The following products, prepared under conditions different from those in Example 1, were prepared according to the method of Example 1.
[0070] The product results obtained in the above examples all show that Mg@SiO2-Pt@ES has been successfully prepared.
[0071] Experimental Example 1: Physical and Chemical Properties and Structural Characterization of Materials (1) Morphological and structural analysis: The Mg@SiO2-Pt@ES powder prepared in Example 1 was dispersed in a solvent, dried, and its microstructure was observed by field emission scanning electron microscopy (SEM); the shell thickness was measured using high-magnification imaging. Figure 3 As shown, where Figure 3 a: Scanning electron microscope (SEM) images of the Mg@SiO2-Pt galvanic cell (first from left), magnified views of individual particles (second from left) and their partial magnifications (third from left), clearly showing the structure and thickness characteristics of the SiO2 shell coating the magnesium core. The image on the right shows the particle size distribution of the Mg@SiO2-Pt galvanic cell, with an average particle size of approximately 30.5 μm. The SiO2 shell forms a continuous and dense coating on the magnesium core surface, with a measured thickness of approximately 100 nm (corresponding to a volume / mass ratio of tetraethyl orthosilicate to magnesium of 1 ml: 250 mg), which helps to regulate the reaction rate of magnesium in the body fluid environment and improve structural stability. Figure 3 c indicates that the surface of the Mg@SiO2-Pt galvanic cell is uniformly coated with a layer of polymer.
[0072] (2) Quantitative analysis of components: Elemental surface scanning and point analysis were performed using an energy-dispersive X-ray spectrometer (EDS) equipped with a SEM at an accelerating voltage of 15 kV. For example... Figure 3 As shown in b, the EDS spectrum confirms the presence of three characteristic elements, Mg, Si, and Pt, in the sample. These three elements are evenly distributed in the microspheres without obvious aggregation.
[0073] (3) Crystal structure analysis: Phase analysis was performed using an X-ray diffractometer (Rigaku D / MAX-2550 V) under Cu Kα radiation (λ=1.5405Å) with a scanning range of 20°–80°. For example... Figure 4 The XRD patterns shown indicate that Mg@SiO2-Pt and Mg@SiO2-Pt@ES fully retain the standard hexagonal crystal system characteristic peaks of metallic magnesium (JCPDS No. PDF#04-0770), and characteristic diffraction peaks of Pt appear at the corresponding positions. No impurity peaks such as magnesium oxide were detected, proving that the preparation process did not damage the crystal structure of the magnesium core.
[0074] (4) Thermogravimetric analysis of coating rate: Using a thermogravimetric analyzer, the temperature was increased to 700℃ in air at a rate of 10℃ / min, and the change in sample mass was monitored. For example... Figure 4 The TGA curves shown indicate that Mg@SiO2-Pt@ES exhibited a significant mass loss step during heating, with a total mass loss of approximately 11%. Combined with the FTIR spectrum at 1720 cm⁻¹... -1 The presence of a carbonyl peak at the ES coating confirms that the mass loss originates from the thermal decomposition of the outer Eudragit S100 polymer coating, demonstrating successful enteric coating and stable content. Mg@SiO2-Pt exhibits slight weight loss (trace water adsorption) at low temperatures, with no significant organic weight loss; however, it gains a significant weight increase of approximately 25% after 500℃. The diffraction peak positions of the ES-coated Mg@SiO2-Pt@ES curve remain unchanged and consistent with the diffraction peak positions of the Mg@SiO2-Pt curve and the characteristic diffraction peak positions of the magnesium (Mg) standard PDF card; indicating that organic coating modification does not alter the Mg crystal phase or cause lattice distortion.
[0075] Experimental Example 2: In vitro hydrogen release and electrochemical performance testing (1) Quantitative analysis of hydrogen release kinetics: Hydrogen generation was quantitatively detected using the methylene blue (MB) probe method. Standard curve plotting: MB simulated intestinal fluid solutions with concentration gradients of 20, 40, 60, 80, 100, and 120 µM were prepared using simulated intestinal fluid (pH 7.4). The absorbance at the maximum absorption wavelength of 660 nm was measured using a UV-Vis spectrophotometer (PerkinElmer Lambda 950), and a concentration-absorbance standard curve was plotted. Release determination: In an argon-protected sealed system, 10 mg of Mg@SiO2 was added to 50 mL of methylene blue solution. At predetermined time points (0–12 hours), 1 mL of supernatant was drawn using a syringe, and the full-band spectrum of 400–800 nm was scanned. The amount of hydrogen generated was calculated based on the decrease in absorbance at 660 nm, compared with the standard curve.
[0076] The results are as follows Figure 5 , Figure 6 As shown, where Figure 5 A shows the release of uncoated Mg particles in simulated intestinal fluid, demonstrating that Mg reacts rapidly in the liquid and releases gas or dissolved substances; Figure 5 B Figure 5 C Figure 5D represents the release behavior of Mg@SiO2 particles under tetraethyl orthosilicate to magnesium volume / mass ratios of 1 ml:125 mg, 1 ml:250 mg, and 1 ml:500 mg, respectively. In simulated intestinal fluid (pH 7.4): Comparative Example 1 (pure magnesium) reacted violently, releasing most of the hydrogen gas within 2 hours. Example 1, with a tetraethyl orthosilicate to magnesium volume / mass ratio of 1 ml:250 mg, exhibited a significant slow-release characteristic, continuously releasing hydrogen gas for up to 8 hours. Example 3 (thick shell) showed an extended release time of 12 hours. These results demonstrate that the SiO2 shell of the present invention effectively achieves long-term sustained release of hydrogen gas.
[0077] (2) Targeted release performance verification: The product was incubated in simulated gastric fluid (SGF, pH = 2.0) and simulated intestinal fluid (SIF, pH = 7.4), respectively. The protective effect of the Eudragit S100 coating in an acidic environment and its dissolution and release characteristics in a neutral environment were verified through macroscopic observation (presence of bubble formation) and microscopic detection (MB probe fading). The results are as follows: Figure 7 As shown, when the product of Example 1 was placed in simulated gastric fluid (pH 2.0), no significant hydrogen release was detected, and the structure remained intact. Upon transfer to simulated intestinal fluid (pH 7.4), the coating dissolved, and hydrogen began to be released. These results demonstrate that the Eudragit S100 coating endows the product with excellent gastric protection and intestinal-targeted release capabilities.
[0078] (3) In vivo release performance: Monitored using ultrasound imaging technology. The distribution and hydrogen release of the Mg@SiO2-Pt@ES galvanic cell in vivo in Example 1 were investigated to verify its intestinal targeted delivery capability. Since hydrogen bubbles exhibit strong echoes under ultrasound, they can be used as a contrast signal to track the site of the reaction. Specifically, gastric ultrasound imaging was performed on 8-week-old male C57BL / 6J mice before administration and 1 hour after oral administration of 200 mg / kg Mg@SiO2-Pt@ES; intestinal ultrasound imaging was performed on 8-week-old male SD rats 4 hours after oral administration of 200 mg / kg Mg@SiO2-Pt@ES. The results are as follows: Figure 8 As shown: Gastric imaging results (verifying acid resistance): Uncoated group (Mg@SiO2-Pt): Localized strong echogenic masses (approximately 3 mm in diameter) were observed in the mouse stomach (below the porta hepatis), accompanied by posterior echo attenuation and microbubble oscillation. This indicates that the uncoated particles reacted prematurely in the acidic gastric environment and released hydrogen gas. Coated group (Mg@SiO2-Pt@ES): No gas signals were observed in the stomach of this group of mice. This demonstrates that the enteric coating Eudragit S100 effectively protects the internal structure, keeping it stable in acidic gastric juice (pH 2.0) without hydrolysis.
[0079] Intestinal imaging results (verifying targeting): Coated group (Mg@SiO2-Pt@ES): Four hours after oral administration to rats, ultrasound images showed numerous dispersed, strongly echogenic microbubbles in the intestinal lumen. Dynamic characteristics: These microbubbles exhibited dynamic movement with intestinal peristalsis and generated strong acoustic scattering signals. Combined with the typical "strong-weak-strong" three-layer structure of the intestinal wall, it was confirmed that these bubbles were generated within the intestine.
[0080] (4) Electrochemical performance test: The standard three-electrode system was used to test the electrochemical performance on an electrochemical workstation (CHI 660E).
[0081] Electrode system construction: Working electrode (WE): The Mg@SiO2-Pt sample from Example 1 was immobilized or dispersed on a conductive substrate and placed in simulated intestinal fluid (SIF). Reference electrode (RE): Ag / AgCl / KCl (3.5 M) electrode. Counter electrode (CE): Platinum / carbon electrode.
[0082] Data acquisition and processing: Measure the Tafel polarization curve to analyze the corrosion potential; perform cyclic voltammetry (CV) scans to determine the redox peak positions.
[0083] Potential conversion: Based on the Nernst equation, the measured potential is converted to a potential relative to the standard hydrogen electrode (NHE): E (NHE) =E (Ag / AgCl) +0.194+0.0592×pH, where E (NHE) E represents the potential of the standard hydrogen electrode. (Ag / AgCl) This represents the potential of the Ag / AgCl electrode.
[0084] The results are as follows Figure 9 As shown, the corrosion potential of the product in Example 1 in simulated body fluid is approximately -0.65 V, and the reduction peak potential measured by cyclic voltammetry (CV) is approximately -0.912 V. This demonstrates that Pt and Mg constitute an effective micron-sized galvanic cell, capable of providing continuous electron transfer (microcurrent).
[0085] Experimental Example 3: Reactive Oxygen Species Scavenging and Radiation Protection at the Cellular Level (1) Cell culture and model construction The experiment consisted of five groups: control group (untreated), irradiation group (IR, 6 Gy), Mg@SiO2+IR, Mg@SiO2-Pt+IR, and amifostine+IR.
[0086] Cell line: Mouse duodenal epithelial cells (MODE-K) were selected and identified by short tandem repeat (STR) sequences and free from mycoplasma contamination.
[0087] Culture conditions: RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin was used, and the medium was cultured in a 37°C, 5% CO2 incubator.
[0088] Radiation model: Cells adhered to the culture medium and grew to the logarithmic growth phase. They were then replaced with fresh medium containing the drug (100 µg / mL Mg@SiO2, 100 µg / mL Mg@SiO2-Pt from Example 1, or 100 µg / mL amifostine) and incubated for 1 hour. Subsequently, they were irradiated with 6 Gy (ROS detection) or 8 Gy (damage detection) γ-rays using a Gammacell 40 Exactor irradiator.
[0089] (2) Detection of intracellular ROS levels and mitochondrial membrane potential Probe incubation: For ROS level detection, after irradiation, the culture medium was removed, the cells were washed with phosphate buffer, and the DCFH-DA fluorescent probe (Beyotime, S1105M) was added. The cells were then incubated at 37°C in the dark for 30 minutes. For mitochondrial membrane potential detection, the JC-1 fluorescent probe (Beyotime, C2006) was added to the irradiated cells, and the cells were incubated at 37°C for 20 minutes.
[0090] Imaging and Quantification: Green fluorescence signals were excited and acquired using a laser scanning confocal microscope (CLSM). The mean fluorescence intensity (MFI) was statistically analyzed using ImageJ software for quantitative analysis.
[0091] The results are as follows Figure 10 As shown, intracellular ROS levels were detected in the MODE-K cell radiation damage model (6 Gy irradiation) using the DCFH-DA probe: In the irradiation group (IR, 6 Gy), ROS fluorescence intensity surged (7.7 times that of the control group). Amifostine + IR significantly reduced ROS levels. Mg@SiO2-Pt + IR showed the best ROS scavenging effect, reducing the level to 14% of that in the irradiation group, significantly better than amifostine + IR. Furthermore, the methylene blue fading experiment showed that the ROS scavenging effect of the Mg@SiO2-Pt + IR group was approximately twice that of the Mg@SiO2 + IR group, indicating that the Mg@SiO2-Pt system can catalyze H2 to active hydrogen (H·), thus possessing a broader-spectrum and more efficient antioxidant capacity. JC-1 staining experiments showed that the mitochondrial membrane potential of cells treated with Mg@SiO2-Pt recovered to near normal levels (red / green fluorescence ratio of 10.90±0.92), which was significantly higher than that of Mg@SiO2+IR, amifostine+IR (lower ratio), and the irradiation group (ratio of 0.16).
[0092] Experimental Case 4: Therapeutic Effect of Radiation Enteritis in Vivo 1. Experimental Methods (1) Animal model and dosing regimen Experimental animals: 8-week-old male C57BL / 6J mice were housed in an SPF-grade animal facility at an ambient temperature of 21°C and humidity of 35%–75%. Sublethal model: Mice received 13 Gy local whole-abdominal irradiation (WAI). Treatment group: Starting 1 hour before irradiation, mice were administered 200 mg / kg of Mg@SiO2-Pt@ES (Example 1) via gavage every 12 hours for 4 days. Positive control: 1 hour before irradiation, mice received a single intraperitoneal injection of 200 mg / kg amifostine. Lethal model: Mice received 8 Gy total body irradiation (TBI) or 17 Gy whole-abdominal irradiation (WAI) with the same administration regimen as above, and survival rates were observed for 50 days.
[0093] (2) Histopathological and immunohistochemical analysis Sample processing: After euthanizing mice, ileum and colon tissue were harvested, the contents were washed with PBS, fixed in 4% paraformaldehyde, and routinely embedded in paraffin. Sections were 4-5 µm thick. H&E staining: Sections were dewaxed with xylene and rehydrated with graded ethanol (100%→70%). Hematoxylin staining was performed for 3-8 minutes, followed by differentiation with hydrochloric acid ethanol, blue resizing with weak alkaline water, and counterstaining with eosin for 1-3 minutes. Villus length and crypt depth were measured under a microscope. Immunohistochemistry (IHC): Antigen retrieval was performed using citrate buffer at high temperature, endogenous peroxidase was blocked with 3% H2O2, and 5% goat serum was used for blocking. Primary antibody (e.g., Ki67, Lysozyme, Nrf2) was incubated overnight, secondary antibody was incubated for 1 hour, DAB staining was performed, and hematoxylin counterstaining was performed.
[0094] (3) Special staining of the mucus barrier system Fixation method: To preserve the mucus layer structure, intestinal tissue was fixed for 24 hours using methanol-Carnoy's solution, rather than ordinary formaldehyde. AB / PAS staining: Sections were stained with Alcian blue / periodic acid-Schiff stain; acidic mucin appeared blue, and neutral mucin appeared purplish-red. Color deconvolution was performed using FIJI software to quantitatively analyze the PAS-positive area. MUC2 immunofluorescence: Mucin MUC2 was labeled, and cell nuclei were counterstained with DAPI (4',6-diamidinyl-2-phenylindole). The physical thickness of the mucus layer was directly measured under a fluorescence microscope.
[0095] (4) ELISA detection of neuropeptide CGRP Protein extraction: Small intestine and colon tissues were collected, mechanically homogenized in pre-cooled PBS, and the supernatant was collected by low-temperature centrifugation. Quantitative analysis: The concentration of CGRP in the tissue homogenate was determined using a specific CGRP ELISA kit (Mlbio, #ml101832) with a double-antibody sandwich method. The OD value was read using a microplate reader, and the content was calculated.
[0096] (5) Behavioral testing The behavioral experiments were conducted in a quiet, temperature-controlled environment with moderate lighting. Data was collected using a video tracking system, and the equipment was cleaned after each experiment to eliminate olfactory interference.
[0097] Treadmill test: The treadmill inclination angle was set at 5°, with a mild electrical stimulation area at the end. Mice underwent 3 days of acclimatization training before testing (5 m / min, 10 min, twice daily). In the formal experiment, mice warmed up at 5 m / min for 3 min, then ran at 10 m / min for 5 min, and then at 15 m / min for 5 min. The number of electrical stimulations received due to stopping running was recorded. Each mouse was tested 3 times, with 30-minute intervals, and the result with the fewest stimulations was taken. Fatigue rotundus test: Mice underwent 3 days of acclimatization training (5 rpm, 5 min, three times daily). In the formal test, the rotation speed was accelerated from 5 rpm to 40 rpm within 300 s, and the fall latency was recorded. Each mouse was tested 3 times, with 30-minute intervals, and the longest latency was taken as the final result.
[0098] 2. Experimental Results (1) Intestinal morphological repair: such as Figure 11 a, Figure 11 As shown in b, in the irradiation group, the villus length shortened to 128 µm, and the crypt depth decreased to 46 µm. In the Mg@SiO2-Pt@ES+IR group, the villus length recovered to 229 µm, and the crypt depth recovered to 114 µm, which is basically close to the level of the healthy control group and significantly better than the amifostine+IR group.
[0099] (2) Neuroimmune regulation (CGRP release): such as Figure 11 c. Figure 11 d、 Figure 11 As shown in Figure e, ELISA analysis revealed that the levels of CGRP (calcitonin gene-related peptide) in the intestinal tissue of mice in the Mg@SiO2-Pt@ES+IR group were increased by 36% (small intestine) and 45% (colon) compared to the irradiation group. In contrast, the Mg@SiO2@ES+IR group showed only a 22% increase (small intestine) and a 13% increase (colon), while the amifostine+IR group showed no significant increase. These results demonstrate that the synergistic effect of "hydrogen gas + electrical stimulation" generated by the Pt-containing galvanic cell can effectively activate the release of CGRP from nerve endings.
[0100] (3) Mucus barrier repair: such as Figure 11 f、 Figure 11 As shown in g, immunofluorescence staining showed that the thickness of the colonic mucus layer (MUC2) in the Mg@SiO2-Pt@ES+IR group not only returned to normal, but also increased by more than 80% compared with the irradiation group. This is attributed to the stimulatory effect of the CGRP-RAMP1 pathway on goblet cells.
[0101] (4) Lethal dose survival rate: such as Figure 12 As shown, under lethal doses (17 Gy WAI or 8 Gy TBI), all mice in the IR group died (survival rate 0%). Mice orally administered Mg@SiO2-Pt@ES showed a 50-day survival rate of 60%-70%, comparable to that of injected amifostine, but avoiding the motor function impairment caused by amifostine (supported by data from treadmill and rotarod experiments).
[0102] In summary, this invention overcomes the limitations of traditional "single-target" drug therapy, achieving multi-dimensional synergistic repair of existing technological deficiencies through a "neuro-immune-barrier" approach: the clinical gold standard drug amifostine primarily works by scavenging free radicals, unable to actively repair damaged intestinal barriers or regulate the immune microenvironment, and its duration of action is short. This invention, Mg@SiO2-Pt@ES, is not only an antioxidant but also a "neuroimmunomodulator." Through the microcurrent and hydrogen gas generated by the galvanic cell, it synergistically activates intestinal nociceptors to release the neuropeptide CGRP. CGRP not only inhibits inflammatory infiltration of neutrophils (reducing MPO-positive cells by 85.1%) but also directly stimulates goblet cells to secrete mucus, increasing the thickness of the intestinal mucus layer by more than 80%, thereby achieving simultaneous anti-inflammatory, antioxidant, and tissue regeneration effects.
[0103] This invention introduces an "active hydrogen" catalytic mechanism, significantly improving the efficiency of reactive oxygen species (ROS) scavenging. Hydrogen molecules (H2) generated by conventional hydrogen therapy or magnesium hydrolysis have limited reducing power and are slow to scavenge highly cytotoxic hydroxyl radicals (·OH). This invention introduces platinum nanoparticles as a catalyst on the magnesium surface, which can convert some H2 into highly reducing atomic active hydrogen (H·). Experimental data demonstrate that Mg@SiO2-Pt@ES achieves a scavenging rate of up to 86% for intracellular ROS (with only 14% residue), and its scavenging efficiency is 1.4 times that of amifostine, exhibiting a broader and more efficient antioxidant capacity.
[0104] This invention solves the problem of "uncontrollable release" of magnesium-based materials, achieving long-term sustained release. Ordinary magnesium microparticles react violently in vivo, releasing most of their hydrogen gas within 2 hours, resulting in a "burst" release that cannot maintain a long-term therapeutic concentration. This invention uses a modified Stöber method to coat the magnesium core with a porous SiO2 shell, effectively controlling water permeation and the rate of magnesium hydrolysis. Technical data shows that this structure achieves continuous hydrogen release and electrical stimulation for 8-12 hours, meeting the need for continuous protection against radiation enteritis.
[0105] This invention, Mg@SiO2-Pt@ES, possesses a precise "intestinal-targeting" function, avoiding gastric side effects. Exposed magnesium reacts violently when passing through the stomach (pH 1.0-3.0), causing premature hydrogen release and bloating, preventing effective delivery to intestinal lesions. This invention utilizes a pH-responsive polymer (Eudragit S100) to construct the outermost protective membrane. This material maintains its structural integrity without gas release in simulated gastric juice (pH 2.0); it dissolves and initiates the reaction only in simulated intestinal juice (pH 7.4). This targeted design ensures that the therapeutic medium (hydrogen + electrical stimulation) precisely acts on the ileum and colon.
[0106] This invention has no toxic side effects and overcomes the systemic toxicity of traditional radioprotective agents. While drugs such as amifostine can improve survival rates, they often cause hypotension, nausea, and vomiting, and experiments have shown that they can cause decreased motor coordination in mice (shortened rotarod test time) and neuronal damage (reduction of Nissl bodies). The magnesium, silicon, and platinum used in this invention are all biosafety materials. Long-term toxicology experiments have shown that oral administration of these microspheres does not cause hypermagnesemia, and there are no pathological changes in major organs. More importantly, the treated mice showed normal performance in terms of exercise endurance, coordination, and cognitive memory function, completely avoiding the neurotoxicity caused by drugs.
[0107] This invention is a non-invasive neuromodulation method that avoids the pain of chemical stimulation. Activating neural pathways with chemokines such as capsaicin can cause intense pain, vomiting, and excessive mucus secretion, leading to poor patient compliance. This invention utilizes in-situ generated "microcurrents" and "endogenous gases" for gentle physical-chemical stimulation, achieving the goal of activating nerve release of CGRP while completely avoiding severe chemical stimulation reactions. It is a safe and comfortable "drug-free" treatment strategy.
[0108] This invention offers high process controllability, enabling advanced technological advancements in customized structure and performance. By simply adjusting the volume / mass ratio of tetraethyl orthosilicate to magnesium, the thickness of the silica shell (from tens to hundreds of nanometers) can be precisely controlled, allowing for on-demand customization of hydrogen release kinetics (release duration and rate) to meet the treatment needs of different intestinal segments or diseases of varying severity. Furthermore, this invention employs an in-situ chemical reduction method, enabling the uniform loading of platinum nanoparticles onto the microsphere surface at room temperature and pressure, eliminating the need for complex high-temperature sintering or expensive vacuum coating equipment. This reduces production energy consumption and costs, facilitating large-scale preparation.
[0109] The above description is only a preferred embodiment of the present invention. It should be noted that those skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, and these all fall within the protection scope of the present invention.
Claims
1. A galvanic functional primary cell composite microsphere, characterized by, include: Metal microspheres are used as the anode; the metal microspheres are magnesium microspheres with an average particle size of 20-50 μm. A porous inorganic shell is coated on the surface of the metal microspheres to control the water permeation rate and inhibit the explosive reaction of magnesium. The porous inorganic shell is a porous silica shell with a thickness of 50-200 nm and the surface of the porous silica shell has amino functional groups. A cathode material, loaded on the pores and surface of the porous inorganic shell, serves as the cathode. The cathode material includes platinum nanoparticles; and a pH-responsive polymer layer, coated on the outermost layer, which remains solid and insoluble in the stomach environment with pH ≤ 5.5, and dissolves in the intestinal environment with pH ≥ 7.
0. The metal microspheres and the cathode form a galvanic cell system after water molecules penetrate into them. Under pH ≥ 7.0 conditions, they generate microcurrents and hydrogen gas, catalyzing the conversion of some hydrogen molecules into highly active atomic hydrogen, activating intestinal nociceptors and promoting the release of endogenous calcitonin gene-related peptide CGRP.
2. The electro-stimuli functional primary cell composite microsphere according to claim 1, wherein, The magnesium microspheres are magnesium-based alloy microspheres, and the magnesium-based alloy is selected from one or more of Mg-Zn alloy, Mg-Ca alloy, Mg-Mn alloy or Mg-Sr alloy.
3. The electro-stimuli functional primary cell composite microsphere according to claim 1, wherein, The cathode material further includes at least one selected from gold nanoparticles, palladium nanoparticles, silver nanoparticles, ruthenium nanoparticles, carbon-based nanomaterials, or conductive polymers; the carbon-based nanomaterials are selected from at least one selected from reduced graphene oxide, carbon nanotubes, or mesoporous carbon; and the conductive polymer is selected from at least one selected from polypyrrole or polyaniline.
4. The electro-stimuli functional primary cell composite microsphere according to claim 1, wherein, The pH-responsive polymer layer is selected from at least one of Eudragit S100, hydroxypropyl methylcellulose phthalate, and cellulose acetate phthalate.
5. A method for preparing the electro-stimulating functional primary cell composite microspheres according to any one of claims 1 to 4, characterized in that, Includes the following steps: A1. Magnesium microspheres are dispersed in a mixture of acetone and ammonia. Tetraethyl orthosilicate is added dropwise under stirring. After reacting for 6-15 hours, the solid and liquid are separated to obtain magnesium microspheres Mg@SiO2 coated with a silica shell. The volume / mass ratio of tetraethyl orthosilicate to magnesium microspheres is 1 ml: (125-500 mg). A2. Disperse the Mg@SiO2 microspheres obtained in step S1 in a mixture of acetone and ammonia water containing 10-30% ammonia by mass, add a mixed solution of 3-aminopropyltriethoxysilane and tetraethyl orthosilicate, and react for 4-8 hours to obtain microspheres with amino functional groups on the surface; wherein, the volume / mass ratio of 3-aminopropyltriethoxysilane, tetraethyl orthosilicate and Mg@SiO2 is (10-30 ml): (30-90 ml): 1 mg; A3. Disperse the amino-functionalized microspheres obtained in step S2 in an aqueous solution of potassium chloroplatinate, add ascorbic acid and carry out an in-situ reduction reaction for 1-3 hours to obtain Mg@SiO2-Pt composite microspheres, wherein the platinum nanoparticles are loaded in the pores and surface of the porous silica shell; wherein the mass ratio of the amino-functionalized microspheres, potassium chloroplatinate, and ascorbic acid is 40-80:2-4:1-2; A4. The Mg@SiO2-Pt composite microspheres obtained in step S3 are dispersed in an isopropanol solution containing Eudragit S100. Using liquid paraffin as the continuous phase, microcapsules are prepared by oil / oil emulsion solvent evaporation method to obtain the galvanic cell composite microspheres Mg@SiO2-Pt@ES.
6. The preparation method according to claim 5, characterized in that, In step A3, the mass ratio of the microspheres with amino functional groups, potassium chloroplatinate, and ascorbic acid is 40:2:
1.
7. Use of the electro-stimulating functional galvanic cell composite microspheres according to any one of claims 1 to 4 for the preparation of a medicament, characterized in that, The drug is used to prevent or treat radiation enteritis or ulcerative colitis.
Citation Information
Patent Citations
Mesoporous silica coated micron magnesium ball core-shell particles and preparation method thereof
CN109498593A
Mesoporous nanosphere with palladium-platinum yolk-eggshell structure for catalyzing methanol oxidation reaction and preparation method of mesoporous nanosphere
CN111276707A
Application of targeted intestinal hydrogen release composition as medicine in treatment of inflammatory bowel disease
CN117899051A
